KGET - CaliPharms, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201312/31/20126/30/20126/30/2011
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development----
Selling General and Administrative214.5813.234674.5871,247.776
Non Recurring----
Others----
Total Operating Expenses214.5813.234674.5871,247.776
Operating Income or Loss-214.5-813.234-674.587-1,247.776
Income from Continuing Operations
Total Other Income/Expenses Net-1.972-103.663-334.524-326.17
Earnings Before Interest and Taxes-214.5-813.234-674.587-1,247.776
Interest Expense-1.972-103.663-334.524-326.17
Income Before Tax-216.472-916.897-1,009.111-1,573.946
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-216.472-916.897-1,009.111-1,573.946
Non-recurring Events
Discontinued Operations---17.21-17.21
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-216.472-916.897-1,026.321-1,573.946
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-216.472-916.897-1,026.321-1,573.946